-
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis
Thursday, October 17, 2024 - 10:55am | 321Read More...Firefly Neuroscience, Inc. (NASDAQ:AIFF) announced a collaboration with Bright Minds Biosciences Inc. (NASDAQ:DRUG) to analyze data from the first-in-human Phase 1 study of BMB-101, Bright Minds’ lead compound for neuropsychiatric disorders and refractory epilepsy. Firefly employed its...
